ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 87 filers reported holding ADURO BIOTECH INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $75,000 | -48.6% | 32,600 | -38.7% | 0.00% | -33.3% |
| Q1 2020 | $146,000 | -65.8% | 53,200 | -85.3% | 0.00% | -50.0% |
| Q4 2019 | $427,000 | +15.7% | 361,800 | +3.9% | 0.01% | +20.0% |
| Q3 2019 | $369,000 | -31.2% | 348,200 | 0.0% | 0.01% | -28.6% |
| Q2 2019 | $536,000 | -61.3% | 348,200 | 0.0% | 0.01% | -58.8% |
| Q1 2019 | $1,386,000 | +381.2% | 348,200 | +219.2% | 0.02% | +325.0% |
| Q4 2018 | $288,000 | – | 109,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |